Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
Watchlist
Price: 7.34 USD 2.09% Market Closed
Market Cap: 261.5m USD

Wall Street
Price Targets

EPRX Price Targets Summary
Eupraxia Pharmaceuticals Inc

Wall Street analysts forecast EPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPRX is 8.9 USD with a low forecast of 6.55 USD and a high forecast of 11.6 USD.

Lowest
Price Target
6.55 USD
11% Downside
Average
Price Target
8.9 USD
21% Upside
Highest
Price Target
11.6 USD
58% Upside
Eupraxia Pharmaceuticals Inc Competitors:
Price Targets
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside
ZYME
Zymeworks Inc
35% Upside
CYTK
Cytokinetics Inc
30% Upside
ARMP
Armata Pharmaceuticals Inc
43% Upside
UTHR
United Therapeutics Corp
1% Upside
RLYB
Rallybio Corp
39% Upside
CSL
CSL Ltd
42% Upside
ADCT
ADC Therapeutics SA
131% Upside

Revenue
Forecast

Revenue Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Net Income
Forecast

Net Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPRX's stock price target?
Price Target
8.9 USD

According to Wall Street analysts, the average 1-year price target for EPRX is 8.9 USD with a low forecast of 6.55 USD and a high forecast of 11.6 USD.

Back to Top